Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03994393
Title Non Small Cell Lung Cancer Trial of Durvalumab and Tremelimumab in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Disease. (ILLUMINATE)
Acronym ILLUMINATE
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Sydney
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
St George Hospital Kogarah New South Wales Australia Details
Liverpool Hospital Liverpool New South Wales Australia Details
The Prince Charles Hospital Chermside Queensland Australia Details
Princess Alexandra Hospital Woolloongabba Queensland Australia Details
Flinders Medical Centre Bedford Park South Australia Australia Details
Royal Hobart Hospital Hobart Tasmania Australia Details
Monash Medical Centre - Clayton Clayton Victoria Australia Details
Peter MacCallum Cancer Centre Melbourne Victoria Australia Details
St Vincent's Hospital (Melbourne) Melbourne Victoria Australia Details
Taiwan Dalin Tzu Chi Hospital Chiayi City Taiwan Details
Taiwan China Medical University Hospital Taichung Taiwan Details
Taiwan Taichung Veterans General Hospital Taichung Taiwan Details
Taiwan National Cheng Kung University Hospital Tainan Taiwan Details
National Taiwan University Hospital Taipei Taiwan Details
Taiwan Taipei Veterans General Hospital Taipei Taiwan Details
Taiwan Tri-Service General Hospital Taipei Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field